These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14688462)

  • 1. Recent advances of molecular targeted agents: opportunities for imaging.
    Dancey JE
    Cancer Biol Ther; 2003; 2(6):601-9. PubMed ID: 14688462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A
    Ann Hematol; 2004; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract]   [Full Text] [Related]  

  • 3. The era of personalized medicine: back to basics.
    Hutchinson L; DeVita VT
    Nat Clin Pract Oncol; 2008 Nov; 5(11):623. PubMed ID: 18957968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular diagnosis of solid tumors].
    Yatabe Y
    Nihon Rinsho; 2005 Mar; 63(3):434-40. PubMed ID: 15773342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.
    Petrelli A; Giordano S
    Curr Med Chem; 2008; 15(5):422-32. PubMed ID: 18288997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanisms of the resistance to molecular targeting agents].
    Akiyama S
    Nihon Rinsho; 2004 Jul; 62(7):1297-304. PubMed ID: 15283147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies for cancer 2004.
    Ross JS; Schenkein DP; Pietrusko R; Rolfe M; Linette GP; Stec J; Stagliano NE; Ginsburg GS; Symmans WF; Pusztai L; Hortobagyi GN
    Am J Clin Pathol; 2004 Oct; 122(4):598-609. PubMed ID: 15487459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002].
    Ray-Coquard I; Blay JY
    Bull Cancer; 2002 Jun; 89(6):567-9. PubMed ID: 12135855
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpacing cancer.
    Dorans K
    Nat Med; 2009 Jul; 15(7):718-22. PubMed ID: 19584848
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tyrosine kinase inhibitor as a therapeutic drug for chronic myelogenous leukemia and gastrointestinal stromal tumor].
    Nakajima M; Toga W
    Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):482-90. PubMed ID: 14639002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
    Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
    World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib: paradigm or anomaly?
    Druker BJ
    Cell Cycle; 2004 Jul; 3(7):833-5. PubMed ID: 15254412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).
    Metro G; Finocchiaro G; Toschi L; Bartolini S; Magrini E; Cancellieri A; Trisolini R; Castaldini L; Tallini G; Crino L; Cappuzzo F
    Rev Recent Clin Trials; 2006 Jan; 1(1):1-13. PubMed ID: 18393776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of imatinib (STI571).
    Buchdunger E; O'Reilly T; Wood J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S28-36. PubMed ID: 12528770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting tyrosine kinases: successes and limitations.
    Arteaga CL
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S79-83. PubMed ID: 14508084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in antineoplastic therapy.
    Kaplow R
    Nurs Clin North Am; 2005 Mar; 40(1):77-94. PubMed ID: 15733948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.